Abstract
BackgroundThe murine transverse aortic constriction (TAC) model is frequently used to investigate molecular mechanisms underlying heart failure. However, limited data is available regarding the expression of mRNAs and circRNAs in murine heart failure progression induced by pressure overload.MethodsTransverse aortic constriction was used to induce pressure overload for 2, 4, and 8 weeks in mice. Echocardiographic measurements in B-mode and M-mode, as well as blood flow Doppler data were collected in mice without (sham) and with (2W-, 4W-, and 8W-post-TAC) pressure load. Hearts were excised and morphology, cardiomyocyte size, and fibrosis were determined. RNA sequencing, circRNA microarray, functional mRNA enrichment analysis, hub gene identification, target miRNA interaction, and competitive endogenous RNA (ceRNA) network construction were conducted.ResultsHeart weight, cardiomyocyte hypertrophy, and fibrosis gradually increased over time in the hearts with pressure overload. The 2W-post-TAC hearts displayed concentric hypertrophy, thickened left ventricular walls, and increased EF and FS. The 4W-post-TAC hearts were characterized by preserved EF and FS, dilated atria, and increased left ventricle (LV) systolic volume. The 8W-post-TAC hearts presented with ventricular and atrial dilation, increased LV systolic and diastolic volume, reduced EF and FS, and increased ejection time (MV ET). mRNA expression analysis suggested that cardiac remodeling, immune response dysregulation, and metabolic disorder were the key cellular events in heart failure progression. Depression in chemotaxis and mitochondrial function were predicted in 4W- and 8W-post-TAC myocardia, respectively. A ceRNA network analysis demonstrated that the circRNAs targeted the expression of genes enriched in metabolism dysregulation in the 2W-post-TAC hypertrophic hearts, while they targeted genes enriched in cardiac remodeling in the 4W-post-TAC EF-preserved hearts and in the suppression of oxidative phosphorylation and cardiac contraction in the 8W-post-TAC EF-reduced hearts.ConclusionOur work empirically demonstrates that distinctive features of heart failure, including ventricular hypertrophy, heart failure with preserved EF (HFpEF), and heart failure with reduced EF (HFrEF) are present in the murine pressure overload models. The three stages of heart failure vary in terms of mRNA and circRNA expression, as well as ceRNA regulation in a manner consistent with their structural, functional, and pathological differences.
Highlights
Despite the improved preventative and therapeutic strategies, the prevalence of heart failure continues to increase worldwide
The functional ejection fraction (EF) indices had significantly increased (79–88%), were stable (55–66%), or decreased (33–40%) in the 2W, 4W, and 8W-post-transverse aortic constriction (TAC) groups, respectively (Figure 2F and Table 1), suggesting the cardiac function progressed from compensatory to decompensatory
We characterized the morphological, functional, and pathological changes occurring in murine heart failure progression and identified distinct hypertrophic, heart failure [with preserved ejection fraction (HFpEF), and HFrEF stages in pressure overload hearts
Summary
Despite the improved preventative and therapeutic strategies, the prevalence of heart failure continues to increase worldwide. The primary feature of the hypertension asymptomatic stage is compensatory hypertrophy of the left ventricle (LV) in response to elevated blood pressure. Longstanding hypertension with sustained pressure overload culminates in left ventricular dilation and reduced ejection fraction (EF). Hypertensive hearts progress from left ventricular hypertrophy to heart failure [with preserved ejection fraction (HFpEF) or reduced ejection (HFrEF)] (Drazner, 2011). Guidelines provided by the American College of Cardiology/American Heart Association for the treatment of heart failure adopts a stage-based approach (Yancy et al, 2017). It is, imperative to distinguish between heart failure development stages, pathological characteristics, and molecular mechanisms in the treatment of heart failure in disease models. Limited data is available regarding the expression of mRNAs and circRNAs in murine heart failure progression induced by pressure overload
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.